{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:19:36Z","timestamp":1794860376093,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["HHSN268201600012I"],"award-info":[{"award-number":["HHSN268201600012I"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["HSN268201600013I"],"award-info":[{"award-number":["HSN268201600013I"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["HHSN268201600014I"],"award-info":[{"award-number":["HHSN268201600014I"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HHSN268201600014I"],"award-info":[{"award-number":["HHSN268201600014I"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","celltherapyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jcyt.2024.07.001","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T12:39:41Z","timestamp":1720269581000},"page":"1522-1531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cryopreservation of mesenchymal stem\/stromal cells using a DMSO-free solution is comparable to DMSO-containing cryoprotectants: results of an international multicenter PACT\/BEST collaborative study"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3474-576X","authenticated-orcid":false,"given":"Theodros","family":"Mamo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl A.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Demorest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali J.","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5856-0500","authenticated-orcid":false,"given":"Allison","family":"Hubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3674-6934","authenticated-orcid":false,"given":"Denese C.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibani","family":"Pati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anna","family":"Reems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7230-4175","authenticated-orcid":false,"given":"Gabriele","family":"Spohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongye","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Stroncek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8734-0996","authenticated-orcid":false,"given":"David H.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2024.07.001_bib0001","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2013.11.033","article-title":"Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients","volume":"20","author":"Introna","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0002","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0003","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3390\/ijms20040982","article-title":"Enhancement of functionality and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for cardiovascular disease","volume":"20","author":"Yun","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0004","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12975-019-00736-5","article-title":"From the lab to patients: a systematic review and meta-analysis of mesenchymal stem cell therapy for stroke","volume":"11","author":"Lalu","year":"2020","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0005","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0006","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","article-title":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial","volume":"3","author":"Wilson","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0007","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jcyt.2022.01.010","article-title":"Assessment of the LOVO device for final harvest of novel cell therapies: a production assistance for cellular therapies multi-center study","volume":"24","author":"Ibenana","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0008","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jcyt.2023.11.003","volume":"26","author":"Shaz","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0009","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fcell.2020.00458","article-title":"Human mesenchymal stromal cell (MSC) characteristics vary among laboratories when manufactured from the same source material: a report by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) collaborative","volume":"8","author":"Stroncek","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0010","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jcyt.2019.07.004","article-title":"Preservation of cell-based immunotherapies for clinical trials","volume":"21","author":"Li","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0011","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcyt.2012.10.002","article-title":"The mesenchymal stromal cells dilemma\u2013does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?","volume":"15","author":"Galipeau","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0012","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/bio.2014.0104","article-title":"Cryopreservation of human mesenchymal stem cells for clinical applications: current methods and challenges","volume":"13","author":"Yong","year":"2015","journal-title":"Biopreserv Biobank"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0013","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cryobiol.2012.10.008","article-title":"Response of the cell membrane-cytoskeleton complex to osmotic and freeze\/thaw stresses. Part 2: the link between the state of the membrane-cytoskeleton complex and the cellular damage","volume":"66","author":"Ragoonanan","year":"2013","journal-title":"Cryobiology"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0014","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-1-4939-3584-0_21","article-title":"Cryopreservation and revival of human mesenchymal stromal cells","volume":"1416","author":"Haack-Sorensen","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0015","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3390\/pharmaceutics13081317","article-title":"Formulation considerations for autologous T cell drug products","volume":"13","author":"van der Walle","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0016","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.12688\/f1000research.16642.1","article-title":"Adverse reactions of dimethyl sulfoxide in humans: a systematic review","volume":"7","author":"Kollerup Madsen","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0017","doi-asserted-by":"crossref","first-page":"104856","DOI":"10.1016\/j.cryobiol.2024.104856","article-title":"Mesenchymal stromal cells derived from various tissues: biological, clinical and cryopreservation aspects: update from 2015 review","volume":"115","author":"Marquez-Curtis","year":"2024","journal-title":"Cryobiology"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0018","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1089\/scd.2016.0347","article-title":"Improved post-thaw function and epigenetic changes in mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions","volume":"26","author":"Pollock","year":"2017","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0019","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/ten.tec.2016.0284","article-title":"Combinations of osmolytes, including monosaccharides, disaccharides, and sugar alcohols act in concert during cryopreservation to improve mesenchymal stromal cell survival","volume":"22","author":"Pollock","year":"2016","journal-title":"Tissue Eng Part C Methods"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0020","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0021","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.918565","article-title":"Optimization of mesenchymal stromal cell (MSC) manufacturing processes for a better therapeutic outcome","volume":"13","author":"Fernandez-Santos","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0023","doi-asserted-by":"crossref","first-page":"155","DOI":"10.15283\/ijsc.2015.8.2.155","article-title":"Cryopreservation of human Wharton's jelly-derived mesenchymal stem cells following controlled rate freezing protocol using different cryoprotectants; a comparative study","volume":"8","author":"Shivakumar","year":"2015","journal-title":"Int J Stem Cells"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0024","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s13287-020-01969-0","article-title":"The combination of trehalose and glycerol: an effective and non-toxic recipe for cryopreservation of human adipose-derived stem cells","volume":"11","author":"Zhang","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0025","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3390\/cells11172691","article-title":"Cryostorage of mesenchymal stem cells and biomedical cell-based products","volume":"11","author":"Linkova","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0026","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0027","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3389\/fimmu.2019.02474","article-title":"Multi-parameter analysis of Biobanked human bone marrow stromal cells shows little influence for donor age and mild comorbidities on phenotypic and functional properties","volume":"10","author":"Andrzejewska","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0028","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/14653249.2011.623691","article-title":"Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing","volume":"14","author":"Francois","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0029","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/stem.1729","article-title":"Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?","volume":"32","author":"Moll","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2024.07.001_bib0030","first-page":"1286","article-title":"Sphingosine-1-phosphate treatment improves cryopreservation efficiency in human mesenchymal stem cells","volume":"13","author":"Oh","year":"2023","journal-title":"Life (Basel)"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924007734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924007734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T05:05:13Z","timestamp":1731387913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324924007734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1465324924007734"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.07.001","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryopreservation of mesenchymal stem\/stromal cells using a DMSO-free solution is comparable to DMSO-containing cryoprotectants: results of an international multicenter PACT\/BEST collaborative study","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}